​

Laboratory Corporation of America (LH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LH Stock Forecast

Laboratory Corporation of America (LH) stock forecast, based on 33 Wall Street analysts, predicts a 12-month average price target of $271.00, with a high of $271.00 and a low of $271.00. This represents a 24.82% increase from the last price of $217.12.

$190 $207 $224 $241 $258 $275 High: $271 Avg: $271 Low: $271 Last Closed Price: $217.12

LH Stock Rating

Laboratory Corporation of America stock's rating consensus is Buy, based on 33 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (78.79%), 7 Hold (21.21%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 33 0 7 26 Strong Sell Sell Hold Buy Strong Buy

LH Price Target Upside V Benchmarks

TypeNameUpside
StockLaboratory Corporation of America24.82%
SectorHealthcare Stocks 35.94%

Price Target Trends

1M3M12M
# Anlaysts-16
Avg Price Target-$271.00$260.33
Last Closing Price$217.12$217.12$217.12
Upside/Downside-24.82%19.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 252125--19
Mar, 252116--19
Feb, 252107--19
Jan, 252117--20
Dec, 242106--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 03, 2025Luke SergottBarclays$271.00$247.869.34%24.82%
Sep 24, 2024Elizabeth AndersonEvercore ISI$240.00$224.726.80%10.54%
Sep 23, 2024Brian TanquilutJefferies$265.00$222.2219.25%22.05%
Aug 05, 2024Michael RyskinBank of America Securities$260.00$236.0010.17%19.75%
Aug 02, 2024Stephanie DavisBarclays$249.00$235.675.66%14.68%
Aug 02, 2024Eric ColdwellRobert W. Baird$277.00$235.6717.54%27.58%
Mar 25, 2024David ToungArgus Research$250.00$212.5017.65%15.14%
Jan 06, 2023Morgan Stanley$303.00$241.4225.51%39.55%
Nov 23, 2022Credit Suisse$305.00$238.0128.15%40.48%
Jul 29, 2022Mizuho Securities$296.00$254.7216.21%36.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 04, 2025CitigroupNeutralBuyupgrade
Jan 07, 2025Evercore ISIOutperformupgrade
Oct 30, 2024HSBCBuyupgrade
Oct 01, 2024Piper SandlerNeutralinitialise
Sep 23, 2024JefferiesBuyBuyhold
Aug 05, 2024Bank of America SecuritiesBuyBuyhold
Aug 02, 2024BarclaysEqual-WeightEqual-Weighthold
Aug 02, 2024UBSBuyBuyhold
Jan 06, 2023Morgan StanleyOverweightOverweighthold
Dec 12, 2022CitigroupNeutraldowngrade

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$15.99$24.58$14.04$4.80------
Avg Forecast$18.41$23.84$17.07$13.54$14.52$16.04$17.65$19.56$21.53$21.67
High Forecast$18.41$23.84$17.07$13.64$14.56$16.28$18.43$21.27$21.84$21.98
Low Forecast$18.41$23.84$17.07$13.48$14.45$15.82$16.45$17.16$21.22$21.36
Surprise %-13.15%3.10%-17.75%-64.55%------

Revenue Forecast

$12B $13B $14B $15B $16B $17B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$13.98B$16.12B$14.88B$12.16B------
Avg Forecast$13.54B$16.01B$14.94B$12.15B$12.99B$13.90B$14.58B$15.40B$16.37B$14.78B
High Forecast$13.54B$16.01B$14.94B$12.16B$13.01B$14.05B$14.86B$15.48B$16.55B$14.94B
Low Forecast$13.54B$16.01B$14.94B$12.14B$12.98B$13.82B$14.25B$15.32B$16.19B$14.61B
Surprise %3.24%0.70%-0.44%0.13%------

Net Income Forecast

$0 $500M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.56B$2.38B$1.28B$418.00M------
Avg Forecast$873.20M$1.89B$1.74B$379.20M$1.22B$1.35B$1.47B$1.62B$1.81B$1.82B
High Forecast$1.15B$2.26B$2.08B$455.04M$1.23B$1.37B$1.55B$1.79B$1.84B$1.85B
Low Forecast$599.01M$1.51B$1.39B$303.36M$1.22B$1.33B$1.39B$1.44B$1.79B$1.80B
Surprise %78.21%25.95%-26.30%10.23%------

LH Forecast FAQ

Is Laboratory Corporation of America stock a buy?

Laboratory Corporation of America stock has a consensus rating of Buy, based on 33 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 26 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Laboratory Corporation of America is a favorable investment for most analysts.

What is Laboratory Corporation of America's price target?

Laboratory Corporation of America's price target, set by 33 Wall Street analysts, averages $271 over the next 12 months. The price target range spans from $271 at the low end to $271 at the high end, suggesting a potential 24.82% change from the previous closing price of $217.12.

How does Laboratory Corporation of America stock forecast compare to its benchmarks?

Laboratory Corporation of America's stock forecast shows a 24.82% upside, underperforming the average forecast for the healthcare stocks sector (35.94%).

What is the breakdown of analyst ratings for Laboratory Corporation of America over the past three months?

  • April 2025: 10.53% Strong Buy, 63.16% Buy, 26.32% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 10.53% Strong Buy, 57.89% Buy, 31.58% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 10.53% Strong Buy, 52.63% Buy, 36.84% Hold, 0% Sell, 0% Strong Sell.

What is Laboratory Corporation of America’s EPS forecast?

Laboratory Corporation of America's average annual EPS forecast for its fiscal year ending in December 2024 is $14.52, marking a 202.50% increase from the reported $4.8 in 2023. Estimates for the following years are $16.04 in 2025, $17.65 in 2026, $19.56 in 2027, $21.53 in 2028, and $21.67 in 2029.

What is Laboratory Corporation of America’s revenue forecast?

Laboratory Corporation of America's average annual revenue forecast for its fiscal year ending in December 2024 is $12.99B, reflecting a 6.79% increase from the reported $12.16B in 2023. The forecast for 2025 is $13.9B, followed by $14.58B for 2026, $15.4B for 2027, $16.37B for 2028, and $14.78B for 2029.

What is Laboratory Corporation of America’s net income forecast?

Laboratory Corporation of America's net income forecast for the fiscal year ending in December 2024 stands at $1.22B, representing an 192.21% increase from the reported $418M in 2023. Projections indicate $1.35B in 2025, $1.47B in 2026, $1.62B in 2027, $1.81B in 2028, and $1.82B in 2029.